Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.08 USD | -0.65% | -3.80% | -7.88% |
Mar. 06 | Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call | |
Mar. 06 | Norway's wealth fund pushes for more women on emerging market company boards | RE |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 368M 269M |
---|---|---|---|---|---|
Net income 2024 * | -48M -35.09M | Net income 2025 * | -78M -57.02M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.66
x | P/E ratio 2025 * |
-5.45
x | Employees | 50 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.73% |
Latest transcript on ESSA Pharma Inc.
1 day | -0.65% | ||
1 week | -3.80% | ||
Current month | -28.39% | ||
1 month | -31.30% | ||
3 months | -21.95% | ||
6 months | +51.43% | ||
Current year | -7.88% |
Managers | Title | Age | Since |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 15-06-23 |
David Wood
DFI | Director of Finance/CFO | 66 | 13-09-30 |
Peter Virsik
COO | Chief Operating Officer | - | 16-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 15-03-04 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 19-07-30 |
Richard Glickman
CHM | Chairman | 65 | 10-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 6.08 | -0.65% | 178,467 |
24-04-25 | 6.12 | -2.08% | 64,770 |
24-04-24 | 6.25 | -2.34% | 41,308 |
24-04-23 | 6.4 | 0.00% | 130,486 |
24-04-22 | 6.4 | +1.27% | 122,377 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.88% | 269M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- EPIX Stock